In the only head-to-head trial of its kind, Radiofrequency Thermal Ablation (RFA) showed statistical superiority over 980nm endovenous laser. Patients treated with the RFA experienced less pain, less bruising, fewer complications and realized quality of life improvement up to four times faster than those treated with endovenous laser ablation.